⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28436968 | 0.72 | — | — | |
| SCHEMBL9445653 | 0.69 | — | — | |
| SCHEMBL10745017 | 0.69 | — | — | |
| SCHEMBL11744345 | 0.67 | — | — | |
| SCHEMBL6052975 | 0.65 | — | — | |
| SCHEMBL10770048 | 0.65 | — | — | |
| SCHEMBL2136788 | 0.65 | — | — | |
| Hydrogen Sulfide SCHEMBL2511821 | 0.63 | — | — | |
| Ammonia Solution, Strong SCHEMBL3855127 | 0.63 | — | — | |
| Hydrogen Sulfide SCHEMBL11883412 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0942722-B1 | TETRAHYDRO-BETA-CARBOLINE COMPOUNDS | LILLY CO ELI (US) | 2004-05-19 | — | — | EP | disclosed |
| EP-0942722-A4 | TETRAHYDRO-BETA-CARBOLINE COMPOUNDS | LILLY CO ELI (US) | 2002-06-05 | — | — | EP | disclosed |
| EP-1098883-A4 | PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS | LILLY CO ELI (US) | 2001-11-14 | — | — | EP | disclosed |
| EP-0749313-A4 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | LILLY CO ELI (US) | 2001-10-24 | — | — | EP | disclosed |
| EP-0983269-A4 | PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS | LILLY CO ELI (US) | 2001-06-27 | — | — | EP | disclosed |
| EP-1098883-A1 | PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS | ELI LILLY AND COMPANY (US) | 2001-05-16 | — | — | EP | disclosed |
| US-6194416-B1 | CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY | 2001-02-27 | — | — | US | disclosed |
| US-6187776-B1 | AZACYCLIC-SUBSTITUTED PYRIDINE DERIVATIVES; ALZHEIMER*S DISEASE, SCHIZOPHRENIA, GASTROINTESTINAL DISORDERS; COGNITION ACTIVATORS | ELI LILLY AND COMPANY | 2001-02-13 | — | — | US | disclosed |
| EP-0788489-A4 | HETEROCYCLIC COMPOUNDS AND THEIR USE | LILLY CO ELI (US) | 2000-11-15 | — | — | EP | disclosed |
| US-6090945-A | HIGH AFFINITY FOR THE 5-HT1C RECEPTOR. | ELI LILLY AND COMPANY (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0745601-A1 | Process for preparing 1,2,5-thiadiazole derivatives | ELI LILLY AND COMPANY (US) | 1996-12-04 | — | — | EP | disclosed |
| WO-1996024351-A1 | TETRAHYDRO-BETA-CARBOLINES, OCTAHYDRO-INDOLO-[2,3-c]QUINOLINES AND OCTAHYDRO-INDOLO-[2,3-c]-QUINUCLIDINES | ELI LILLY AND COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| WO-1996012711-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE | ELI LILLY AND COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |
| EP-0709381-A1 | Heterocyclic compounds and their preparation and use | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |
| US-5508284-A | TREATING 5-HYDROXYTRYPTAMINE MODULATION | ELI LILLY AND COMPANY (US) | 1996-04-16 | — | — | US | disclosed |
| US-5500431-A | ANTISEROTONINE AGENTS; SEXUAL AND EATING DISORDERS | ELI LILLY AND COMPANY (US) | 1996-03-19 | — | — | US | disclosed |
| WO-1995024200-A1 | METHOD FOR TREATING 5HT2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |
| WO-1995024191-A1 | 8-SUBSTITUTED TETRAHYDRO-BETA-CARBOLINES | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |
| WO-1994023720-A1 | TETRAHYDRO-BETA-CARBOLINES | ELI LILLY AND COMPANY (US) | 1994-10-27 | — | — | WO | disclosed |
| EP-0620222-A2 | Tetrahydro-beta-carbolines | ELI LILLY AND COMPANY (US) | 1994-10-19 | — | — | EP | disclosed |